Back

Meta-analysis of the safety of outpatient sotalol initiation in clinical practice

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Miscellaneous on atrial fibrillation Antiarrhythmic Drug Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mohamed Shelig

Marshall University, Huntington (United States of America)

3 More presentations in this session

Presentation thumbnail
Association between liver fibrosis and atrial fibrillation: a prospective cohort study and mediation analysis
Doctor Z. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
History of bleeding is associated with higher risk of cardiovascular outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase III
Doctor B. Corica (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Sex-specific analysis of atrial fibrillation in developing nations
Doctor F. Almanzar Dihmes (Santo Domingo, DO)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous on atrial fibrillation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Smaller trials, trial updates, and other studies: devices, cardiac arrest and atrial fibrillation ablation
thumbnail
Congress Session
Late-Breaking Clinical Trials: recent advances in CIED therapies
thumbnail
Congress Session
Key takeaways from ESC Congress 2025 together with World Congress of Cardiology (2)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources